CD4 and neoplasm: Fourteen patients with the PD‐1 expression were weakly positive in tumor microenvironment, meanwhile the median percentage and MFI of PD‐1 on CD4+ T cells were 17.28% (range: 3.25–46.45%) and 398.5 (range: 244–1590).